大博醫療(002901.SZ)取得椎體成形系統醫療器械註冊證
格隆匯1月16日丨大博醫療(002901.SZ)公佈,公司於近日取得國家藥品監督管理局頒發的椎體成形系統《醫療器械註冊證》(國械注準20193041003),該產品適用於椎體壓縮性骨折時,對椎體進行撐開復位及骨水泥注入的輔助工具。
產品名稱椎體成形系統;註冊證編號國械注準20193041003;註冊證有效期有效期至2024年12月11日;該產品由椎體擴張球囊導管和椎體成形手術器械組成,椎體成形手術器械包括擴張套管、骨水泥推注器、穿刺套管、椎體鑽和導針。該產品為滅菌包裝。
上述產品註冊證的取得,豐富和完善了公司的脊柱產品線,有利於進一步增強公司的綜合競爭力,預計將對公司未來的經營產生積極的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.